Deutsch
Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Deutsch
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Options
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Grifols
(NASDAQ:GRFS)
Intraday
$6.33
-0.06
[-0.94%]
After-Hours
$6.33
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$6.33
-0.06
[-0.94%]
At close: Apr 25
$6.33
0
[0.00%]
After Hours: 9:28AM EDT
Get Report
Watch
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Grifols Stock (NASDAQ:GRFS)
Grifols Stock (NASDAQ: GRFS)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, April 22, 2024
Grifols Achieves Results From Phase 4 Study Of Fanhdi In Patients With Von Willebrand Disease
Benzinga Newsdesk
-
3 days ago
Thursday, April 11, 2024
CarMax Reports Downbeat Earnings, Joins Lovesac And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
-
Apr 11, 2024, 8:03AM
Thursday, April 04, 2024
Grifols Says Regarding Adjustments For Cost Savings, Operational Improvements, And Synergies Made To Consolidated EBITDA Under Credit Agreement, Confirms That This Is Not Used As An Alternative Measure Of Performance
Benzinga Newsdesk
-
Apr 4, 2024, 12:12PM
Grifols Achieves Milestone In Transfusion Medicine With CE Mark For Procleix ArboPlex Assay
Benzinga Newsdesk
-
Apr 4, 2024, 4:13AM
Friday, March 22, 2024
Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Mar 22, 2024, 2:39PM
Grifols shares are trading lower as investors digest the CNMV's review of the company's financial reports which found "deficiencies" but no significant errors.
Benzinga Newsdesk
-
Mar 22, 2024, 12:23PM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Mar 22, 2024, 9:06AM
Lululemon Issues Weak Outlook, Joins Nike And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor
-
Mar 22, 2024, 5:40AM
Thursday, March 21, 2024
Spanish Stock Market Supervisor CNMV Says There Were Also Deficiencies In The Presentation Of Alternative Performance Measures, In Particular EBITDA And Debt/EBITDA Ratio; CNMV Sees No Need For Grifols To Restate Accounts; Says At Present, It's Not Possible To Prejudge Potential Consequences Of Any Sanctions For Grifols
Benzinga Newsdesk
-
Mar 21, 2024, 2:59PM
Spanish Stock Market Supervisor CNMV Says However, We Have Found Deficiencies In Detail, Accuracy Of Breakdowns, Explanatory Notes In Some Years Of The Period Analyzed
Benzinga Newsdesk
-
Mar 21, 2024, 2:57PM
Spanish Stock Market Supervisor CNMV Says Investigations Not Identified Significant Errors In Quantitative Magnitudes Of Grifols' Main Financial Statements For The Period Analyzed; Have Not Found Evidence That The Financial Debt Reported By Grifols Does Not Correspond To Reality
Benzinga Newsdesk
-
Mar 21, 2024, 2:57PM
Thursday, March 14, 2024
Grifols Gets Downgraded: Fitch, S&P Flag Cash Flow Concerns At Pharma Company
Vandana Singh
-
Mar 14, 2024, 4:23PM
Grifols shares are trading lower after Fitch and S&P reportedly downgraded their credit ratings of the stock.
Benzinga Newsdesk
-
Mar 14, 2024, 3:57PM
Grifols Expects To Address Our 2025 Maturities Efficiently In The First Half Of 2024, Considering The SRAAS Disposal Proceeds And Other Available Options; Executing These Commitments Will Help Grifols Achieve Leverage Levels That Should Serve As Basis For An Improvement On Credit Rating Agencies' Scorecards
Benzinga Newsdesk
-
Mar 14, 2024, 10:03AM
Grifols Continues To Conduct Business As Usual And Remain Fully Committed To Implementing Its Plan To Reduce Leverage Through Accelerated EBITDA Improvement And Proceeds From $1.8B Shanghai Raas (SRAAS) 20% Sale; Such Disposal Execution Continues To Follow Already-Stated Timings And Is Expected To Close In The H1 Of 2024
Benzinga Newsdesk
-
Mar 14, 2024, 10:02AM
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
-
Mar 14, 2024, 9:06AM
Tuesday, March 12, 2024
Deutsche Bank Downgrades Grifols to Sell
Benzinga Newsdesk
-
Mar 12, 2024, 5:42PM
Friday, March 08, 2024
Why Marvell Technology Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Mar 8, 2024, 1:47PM
Crude Oil Falls Over 1%; Willdan Group Shares Spike Higher
Avi Kapoor
-
Mar 8, 2024, 12:43PM
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
-
Mar 8, 2024, 12:31PM
Smith & Wesson Brands Reports Upbeat Earnings, Joins America's Car-Mart, HCI Group And Other Big Stocks Moving Higher On Friday
Avi Kapoor
-
Mar 8, 2024, 10:08AM
Market-Moving News for March 8th
Benzinga Newsdesk
-
Mar 8, 2024, 8:44AM
Grifols shares are trading higher after the company announced it published its consolidated annual accounts for 2023.
Benzinga Newsdesk
-
Mar 8, 2024, 7:27AM
Grifols Said Compared To Consolidated Interim Financial Statements For 2023 Published On Feb 29, 2024, This Integration Does Not Impact The Income Statement, Nor Does It Have A Material Impact On Key Metrics
Charles Gross
-
Mar 8, 2024, 5:15AM
Grifols Said The Annual Accounts For 2023 Include The Integration Of The JV With Immunotek According To IFRS 11 Joint Arrangements; Aligns Accounting Treatment With The Essence Of The Contract, Last Modified In June 2023
Charles Gross
-
Mar 8, 2024, 5:11AM
Grifols Earlier Announced It Published Its Consolidated Annual Accounts For 2023, Which Include The Non-Financial Information Statement; Accounts Received An Unqualified Opinion From Their Auditor, KPMG
Charles Gross
-
Mar 8, 2024, 5:09AM
Wednesday, March 06, 2024
Grifols shares are trading lower after Gotham City Research issued a report on the company.
Benzinga Newsdesk
-
Mar 6, 2024, 2:26PM
Why United Natural Foods Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
-
Mar 6, 2024, 1:54PM
Spanish Healthcare Firm Grifols Hit With New Gotham City's Short Report, Faces Questions Regarding Transparency, Integrity, Ethical Conduct
Vandana Singh
-
Mar 6, 2024, 1:21PM
Why CrowdStrike Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
-
Mar 6, 2024, 8:14AM
Oddity Tech Posts Q4 Results, Joins Ross Stores And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Avi Kapoor
-
Mar 6, 2024, 5:00AM
Thursday, February 29, 2024
Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Feb 29, 2024, 2:00PM
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
-
Feb 29, 2024, 12:32PM
Wednesday, February 14, 2024
Grifols Announces Topline Phase 3 Fibrinogen Clinical Trial Results
Benzinga Newsdesk
-
Feb 14, 2024, 3:18AM
Monday, February 12, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
-
Feb 12, 2024, 12:35PM
Monday, February 05, 2024
Grifols' Víctor Grifols Deu Has Decided To Conclude His Executive Role As Chief Operating Officer, While Remaining On Grifols' Board Of Directors As A Non-Executive Director; Thomas Glanzmann Will Continue As Executive Chairman; Company Names Nacho Abia As Chief Executive Officer
Benzinga Newsdesk
-
Feb 5, 2024, 11:55AM
Grifols Launches New Vial Sizes Of Prolastin, The Alpha1 Antitrypsin Augmentation Therapy Most Prescribed Worldwide
Charles Gross
-
Feb 5, 2024, 5:39AM
Friday, January 26, 2024
Grifols Files Lawsuit In U.S. District Court For Southern District Of New York Against Daniel Yu, Gotham City Research, General Industrial Partners, Cyrus De Weck, And Their Affiliates
Benzinga Newsdesk
-
Jan 26, 2024, 1:01PM
Thursday, January 25, 2024
Peering Into Grifols's Recent Short Interest
Benzinga Insights
-
Jan 25, 2024, 2:30PM
Tuesday, January 23, 2024
Grifols Has Submitted Response On Gotham City Report To Spanish Supervisor CNMV; Spanish Supervisor Said In A Statement That Additional Information From Grifols May Be Required
Charles Gross
-
Jan 23, 2024, 6:18AM
Friday, January 19, 2024
Scranton Acquired Plasma Companies From Grifols To Help Grifols
Benzinga Newsdesk
-
Jan 19, 2024, 9:22AM
Grifols Will Respond "Very, Very Soon" To Spanish Stock Market Supervisor Request
Benzinga Newsdesk
-
Jan 19, 2024, 9:21AM
Scranton, An Investment Company Linked To Grifols, Should Offer Public Explanation At Some Point After Hedge Fund Report
Benzinga Newsdesk
-
Jan 19, 2024, 9:20AM
Spain's Stock Market Supervisor Asked Grifols To Explain Certain Transactions It Had Already Explained In 2019
Benzinga Newsdesk
-
Jan 19, 2024, 9:19AM
Thursday, January 18, 2024
Spanish Healthcare Firm Grifols' Reputational Damage and Debt Woes: European Central Bank Probes Lenders
Vandana Singh
-
Jan 18, 2024, 7:33AM
Wednesday, January 17, 2024
European Central Bank Asks Some lenders To Detail Exposure To Spain's Grifols, Related Assets
Benzinga Newsdesk
-
Jan 17, 2024, 1:20PM
Monday, January 15, 2024
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
-
Jan 15, 2024, 8:05AM
Friday, January 12, 2024
Why Wipro Shares Are Trading Higher By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
-
Jan 12, 2024, 1:28PM
Delta Air Lines Reports Q4 Results, Joins United Airlines, American Airlines And Other Big Stocks Moving Lower On Friday
Avi Kapoor
-
Jan 12, 2024, 10:39AM
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
-
Jan 12, 2024, 8:05AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch